Ariana Winder started her clinical research career in 2011 as a general and surgical oncology research assistant at Geisinger (considered “the most progressive health system on the planet” by Eric Topol, MD). Her expertise is facilitating well-designed evidence generation capabilities in dovetail with exceptional research participant experiences. Her vision for technology in research is to ‘make it easy’ for subject matter experts to do what they do best and to support a translational bridge between basic, clinical, and population health sciences.
Prior to joining Javara, she has served in various research leadership roles at two top-50 funded health systems and two B2B software as a service (SaaS) vendors with EDC, clinical data (EHR/EMR/CDW) integrations, clinical supply forecasting, and IRT products. Her experience spans ~4k personal consents working 1:1 with patients and 50-8k sponsor and investigator-initiated study portfolios serving 400+ global clients in pharmaceutical, biotechnology, enterprise academic, not-for-profits, and government agency sectors. Her work has impacted a wide spectrum of applications including eConsent (trial specific and broad consent), ePROs, wearables, longitudinal data management, system migrations, government pandemic contact tracing databases, protocol optimization, trial accrual plans, large omic biobanking initiatives, genetic return of results, and a multitude of insights generation.
She holds certifications as a clinical research professional and a clinical data manager. Her primary research interests are focused on informatics approaches to neuroimmunology and “nudges” (Thaler, 2008) to improve healthspan.
Ariana received her Bachelor of Science in pre-medical biology and bioethics from Bloomsburg University of Pennsylvania after an appointment at the United States Air Force Academy and her Master of Science in clinical research from the Massachusetts College of Pharmacy and Health Sciences (MCPHS). In addition to her professional work, Ariana has been a passionate member and supporter of multiple sclerosis efforts since her first National Multiple Sclerosis Society MS150 bike ride on Minitab’s corporate team in 2002.
